Alnylam Pharmaceuticals
ALNY
#772
Rank
$32.62 B
Marketcap
$243.80
Share price
-0.70%
Change (1 day)
-46.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company